Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (9925)	1/31/2007 7:20:10 AM
From: Iamarangerboy	Read Replies (1) \| Respond to of 10280

Sepracor earnings nearly triple marketwatch.com NEW YORK (MarketWatch) -- Sepracor Inc. (SEPR : Sepracor Inc News , chart, profile, more Last: 60.21-0.52-0.86% 7:04am 01/31/2007 SEPR60.21, -0.52, -0.9% ) said fourth-quarter earnings rose to $99.1 million, or 85 cents a share, from $36.9 million, or 31 cents a share, a year earlier. The results include a 12 cents a share charge for stock-based compensation. Revenue increased to $357.2 million from last year's $311.1 million. Analysts surveyed by Thomson Financial had been expecting earnings of 62 cents a share and revenue of $341.4 million, on average. Shares of the Marlborough, Mass. drug developer closed Tuesday down 52 cents at $60.21. End of Story